2025 annual financial data
ProQR Therapeutics 2025 Financial results
Direct answer
Revenue was 15,278,232 EUR.
Operating income was -42,154,897 EUR and net income was -40,519,110 EUR.
Operating cash flow was -50,707,480 EUR.
Get free ProQR Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 15,278,232 EUR
- Operating income
- -42,154,897 EUR
- Net income
- -40,519,110 EUR
- Operating cash flow
- -50,707,480 EUR
Explore related company data
View all 2025 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all ProQR Therapeutics financial years